Baird Financial Group Inc. increased its stake in shares of Acadia Healthcare Company, Inc. (NASDAQ:ACHC) by 42.7% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 762,975 shares of the company’s stock after buying an additional 228,196 shares during the period. Baird Financial Group Inc. owned approximately 0.87% of Acadia Healthcare Company worth $25,254,000 at the end of the most recent reporting period.
Other institutional investors also recently made changes to their positions in the company. Amalgamated Bank raised its stake in Acadia Healthcare Company by 38.0% in the second quarter. Amalgamated Bank now owns 9,780 shares of the company’s stock worth $510,000 after buying an additional 2,691 shares in the last quarter. Legal & General Group Plc raised its stake in Acadia Healthcare Company by 6.0% in the second quarter. Legal & General Group Plc now owns 5,366 shares of the company’s stock worth $297,000 after buying an additional 302 shares in the last quarter. EverPoint Asset Management LLC acquired a new stake in Acadia Healthcare Company during the second quarter worth $18,559,000. Boxer Capital LLC acquired a new stake in Acadia Healthcare Company during the second quarter worth $6,522,000. Finally, Polar Capital LLP raised its stake in Acadia Healthcare Company by 43.5% in the second quarter. Polar Capital LLP now owns 330,000 shares of the company’s stock worth $18,282,000 after buying an additional 100,000 shares in the last quarter.
Shares of Acadia Healthcare Company, Inc. (NASDAQ:ACHC) traded down 0.10% on Friday, reaching $38.88. 614,552 shares of the company’s stock traded hands. The firm’s 50-day moving average is $37.32 and its 200-day moving average is $42.97. The stock’s market cap is $3.40 billion. Acadia Healthcare Company, Inc. has a 52-week low of $32.54 and a 52-week high of $65.00.
TRADEMARK VIOLATION NOTICE: This piece was first published by sleekmoney and is owned by of sleekmoney. If you are viewing this piece on another site, it was illegally copied and reposted in violation of US & international copyright and trademark legislation. The correct version of this piece can be read at http://sleekmoney.com/baird-financial-group-inc-raises-position-in-acadia-healthcare-company-inc-achc/1655137.html.
A number of equities research analysts recently weighed in on the stock. Zacks Investment Research upgraded shares of Acadia Healthcare Company from a “sell” rating to a “hold” rating in a report on Tuesday, December 20th. Cantor Fitzgerald reiterated a “buy” rating on shares of Acadia Healthcare Company in a research note on Thursday, December 15th. Raymond James Financial, Inc. upgraded shares of Acadia Healthcare Company from an “outperform” rating to a “strong-buy” rating and set a $65.00 price objective for the company in a research note on Thursday, November 3rd. Royal Bank Of Canada decreased their price objective on shares of Acadia Healthcare Company from $78.00 to $59.00 and set an “outperform” rating for the company in a research note on Wednesday, October 19th. Finally, Citigroup Inc. assumed coverage on shares of Acadia Healthcare Company in a research note on Wednesday, January 4th. They issued a “buy” rating and a $43.00 price objective for the company. Two research analysts have rated the stock with a sell rating, two have issued a hold rating, twelve have assigned a buy rating and one has issued a strong buy rating to the company. The stock has an average rating of “Buy” and a consensus target price of $61.93.
In related news, Director Reeve B. Waud sold 28,000 shares of the stock in a transaction that occurred on Friday, December 16th. The stock was sold at an average price of $34.58, for a total transaction of $968,240.00. Following the completion of the sale, the director now owns 55,673 shares in the company, valued at approximately $1,925,172.34. The sale was disclosed in a filing with the SEC, which is available through the SEC website. Also, Director Reeve B. Waud sold 14,000 shares of the stock in a transaction that occurred on Monday, December 12th. The shares were sold at an average price of $35.79, for a total value of $501,060.00. Following the sale, the director now owns 55,673 shares of the company’s stock, valued at approximately $1,992,536.67. The disclosure for this sale can be found here. In the last quarter, insiders have sold 98,000 shares of company stock valued at $3,418,520. 17.20% of the stock is currently owned by corporate insiders.
Acadia Healthcare Company Company Profile
Acadia Healthcare Company, Inc is a provider of behavioral healthcare services. The Company operates in two segments: U.S. Facilities and U.K. Facilities. The Company develops and operates inpatient psychiatric facilities, residential treatment centers, group homes, substance abuse facilities and facilities providing outpatient behavioral healthcare services to serve the behavioral health and recovery needs of communities throughout the United States, the United Kingdom and Puerto Rico.
Want to see what other hedge funds are holding ACHC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Acadia Healthcare Company, Inc. (NASDAQ:ACHC).
This story was originally published by sleekmoney (http://sleekmoney.com) and is the sole property of sleekmoney. If you are reading this article on another website, that means this article was illegally copied and re-published to this website in violation of U.S. and International copyright law. You can view the original version of this story at http://sleekmoney.com/baird-financial-group-inc-raises-position-in-acadia-healthcare-company-inc-achc/1655137.html
Receive News & Ratings for Acadia Healthcare Company Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Acadia Healthcare Company Inc. and related companies with MarketBeat.com's FREE daily email newsletter.